Susan E. Alters

Susan Alters co-leads in vivo pharmacology and pre-clinical planning at PIC Therapeutics, working with the company since February 2021. Susan gained extensive knowledge of basic research, IND-enabling bioanalytical, PK/PD, toxicology, and clinical development from a variety of past positions at Aeglea Biotherapeutics, Amunix, Targesome, Surromed, and Applied Immune Sciences/RPR GenCell.

Dr. Alters is Principal Consultant and President of Alters Bioscience Consulting, where she brings industry expertise to companies developing novel therapeutics. Dr. Alters specializes in setting and implementing overall drug development strategies required to move preclinical therapeutics through clinical development. Dr. Alters proven track record of scientific productivity is emphasized by her contributions to numerous IND and BLA submissions, publications, and patents on preclinical and translational drug development.

Dr. Alters received her Ph.D. from Stanford University in Cancer Biology, and subsequently performed postdoctoral research in Immunology at Stanford University Medical Center.